JFS Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5
| Closed | -$361 | – | 1987 |
|
|
2023
Q2 | $361 | Buy |
5
+2
| +67% | +$144 | ﹤0.01% | 1802 |
|
|
2023
Q1 | $221 | Hold |
3
| – | – | ﹤0.01% | 1814 |
|
|
2022
Q4 | $200 | Sell |
3
-2
| -40% | -$133 | ﹤0.01% | 1828 |
|
|
2022
Q3 | $0 | Buy |
5
+2
| +67% | – | ﹤0.01% | 1837 |
|
|
2022
Q2 | $0 | Sell |
3
-5
| -63% | – | ﹤0.01% | 1850 |
|
|
2022
Q1 | $1K | Buy |
8
+5
| +167% | +$625 | ﹤0.01% | 1674 |
|
|
2021
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1809 |
|